Myeloperoxidase directs properdin-mediated complement activation

Journal of Innate Immunity

Volumn 6, Issue 4, 2014, Pages 417-425

  O'Flynn, Joseph ^a   Dixon, Karen O ^a   Faber Krol, Maria C ^a   Daha, Mohamed R ^a   Van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alternative pathway; Complement; Myeloperoxidase; Neutrophils; Properdin

Indexed keywords

AZUROCIDIN; CATHEPSIN G; EDETIC ACID; ELASTASE; ENZYME; LYSOZYME; MYELOBLASTIN; MYELOPEROXIDASE; PROPERDIN; ANTIMICROBIAL CATIONIC PEPTIDE; CARRIER PROTEIN; CATIONIC ANTIMICROBIAL PROTEIN CAP 37, HUMAN; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; PANCREATIC ELASTASE; PEROXIDASE; PLASMA PROTEIN; PROTEIN BINDING;

ANCA ASSOCIATED VASCULITIS; ARTICLE; COMPLEMENT ACTIVATION; HUMAN; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME BINDING; HUMAN CELL; PROTEIN INTERACTION; IMMUNOLOGY; METABOLISM;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CARRIER PROTEINS; CATHEPSIN G; COMPLEMENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; IMMUNITY, INNATE; MURAMIDASE; MYELOBLASTIN; NEUTROPHILS; PANCREATIC ELASTASE; PEROXIDASE; PROPERDIN; PROTEIN BINDING;

EID: 84902792806     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000356980     Document Type: Article

References (24)

1. Walport MJ: Complement. First of two parts. N Engl J Med 2001; 344:1058-1066.
2. Fearon DT, Austen KF: Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med 1975; 142:856-863.
3. Hourcade DE: The role of properdin in the assembly of the alternative pathway C3 con-vertases of complement. J Biol Chem 2006; 281:2128-2132.
4. Kemper C, Atkinson JP, Hourcade DE: Pro-perdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol 2010; 28: 131-155.
5. Xu W, Berger SP, Trouw LA, de Boer HC, Schlagwein N, Mutsaers C, Daha MR, van Kooten C: Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol 2008; 180:7613-7621.
6. Kemper C, Mitchell LM, Zhang L, Hourcade DE: The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci USA 2008; 105:9023-9028.
7. Camous L, Roumenina L, Bigot S, Brachemi S, Fremeaux-Bacchi V, Lesavre P, Halbwachs-Mecarelli L: Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood 2011; 117:1340-1349.
8. Botto M, Lissandrini D, Sorio C, Walport MJ: Biosynthesis and secretion of complement component (C3) by activated human poly-morphonuclear leukocytes. J Immunol 1992; 149:1348-1355.
9. Okuda T: Murine polymorphonuclear leukocytes synthesize and secrete the third component and factor B of complement. Int Immunol 1991; 3:293-296.
10. Wirthmueller U, Dewald B, Thelen M, Scha-fer MK, Stover C, Whaley K, North J, Eggle-ton P, Reid KB, Schwaeble WJ: Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 1997; 158:4444-4451.
11. Venge P, Olsson I: Cationic proteins of human granulocytes. 6. Effects on the complement system and mediation of chemotactic activity. J Immunol 1975; 115:1505-1508.
12. Shingu M, Nonaka S, Nishimukai H, Nobu-naga M, Kitamura H, Tomo-Oka K: Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Clin Exp Immunol 1992; 90:72-78.
13. Vogt W: Complement activation by myelo-peroxidase products released from stimulated human polymorphonuclear leukocytes. Im-munobiology 1996; 195:334-346.
14. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jen-nette JC: Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007; 170:52-64.
15. Ballieux BE, Zondervan KT, Kievit P, Hagen EC, van Es LA, van der Woude FJ, Daha MR: Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endo-thelial damage through ADCC? Clin Exp Immunol 1994; 97:52-60.
16. Bjornson AB, Michael JG: Factors in human serum promoting phagocytosis of Pseudo-monas aeruginosa. 1. Interaction of opsonins with the bacterium. J Infect Dis 1974; 130(suppl):S119-S126.
17. Pepys MB, Butterworth AE: Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation. Clin Exp Immunol 1974; 18:273-282.
18. Gaarkeuken H, Siezenga MA, Zuidwijk K, van Kooten C, Rabelink TJ, Daha MR, Berger SP: Complement activation by tubular cells is mediated by properdin binding. Am J Physiol Renal Physiol 2008; 295:F1397-F1403.
19. Kallenberg CG, Heeringa P: Complement is crucial in the pathogenesis of ANCA-associ-ated vasculitis. Kidney Int 2013; 83:16-18.
20. Maison CM, Villiers CL, Colomb MG: Prote-olysis of C3 on U937 cell plasma membranes. Purification of cathepsin G. J Immunol 1991; 147:921-926.
21. Kessenbrock K, Krumbholz M, Schoner-marck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE: Netting neutro-phils in autoimmune small-vessel vasculitis. Nat Med 2009; 15:623-625.
22. Hewins P, Morgan MD, Holden N, Neil D, Williams JM, Savage CO, Harper L: IL-18 is upregulated in the kidney and primes neutro-phil responsiveness in ANCA-associated vas-culitis. Kidney Int 2006; 69:605-615.
23. Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, Zheng X, E J, Kallenberg CG, Zhao MH: Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vas-culitis. J Clin Immunol 2009; 29:282-291.
24. Gou SJ, Yuan J, Chen M, Yu F, Zhao MH: Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2013; 83:129-137.